Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSPREy: Methadone vs Short-acting Opioids for Outpatient Surgery Pain
NCT03726268Phase 4Completed
- Sponsor
- Duke University
- Start
- Nov 2018
- Primary completion
- Jul 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of methadone in postoperative pain, sponsored by Duke University. Primary endpoint: Total 30 Day Post-discharge Home Opioid Use. Started Nov 2018; status: completed.
02
Drugs
methadone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03726268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03726268.